In this study, we aimed to delineate the mechanism by which Wogonin suppressed transcription of Nrf2 in resistant CML cells and further evaluate the reversal effects of Wogonin on the established animal models. The gene discussed is NFE2L2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.